FGK Clinical Research GmbH
Biotechnology
-
Short facts
-
- Research & Development
- Service Provider
- Year founded 2002
- 97 Employees (site)
- Turnover: 5m - <10m EUR
Products/services: Clinical Research; CRO; biotech, medical device, pharmaceutical companies; clinical development all phases; clinical trials; project design; project management;monitoring; biostatistical analysis; Clinical Study Report; legal representation services; regulatory affairs; pharmacovigilance services.
Basic data
Company
FGK Clinical Research GmbH
Street
Heimeranstr. 35
PC / City
80339 München
County
Upper Bavaria
Phone
+49 89 893119-0
Fax
+49 89 893119-20
Homepage
Language skills
Czech, English, French, German, Hungarian, Italian, Polish, Russian, Spanish
Contact person
Management, Purchasing, Research & development, Cooperation: Martin Krauss (Mr.)
Management: Dr. Edgar Fenzl (Mr.)
Profile/competences
Core competencies
FGK Clinical Research is a Munich-based CRO which cooperates with biotech, medical device and pharmaceutical companies. We cover all the phases and areas of clinical development and conduct studies all over Europe. We are currently employing more than 100 employees – all very experienced in their own fields and trained according to the latest standards in clinical research.
Our company has been operating for more than thirteen years and has conducted clinical trials in a wide range of indications, especially in oncology, CNS, dermatology and cardiology.
We provide a whole range of services – starting with a project design, project management and monitoring, up until an overall biostatistical analysis of collected data by means of the latest technological tools and Clinical Study Report. We also provide legal representation services to our non-European customers.
Key sectors / sub-sectors
- Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
NACE industries
- Scientific research and development 72
- Research and experimental development on natural sciences and engineering 72.1
- Research and experimental development on biotechnology 72.11
Certifications
not available
Sales markets - target industries
Biotechnologie-Unternehmen, Medizinprodukte-Hersteller, Pharmazeutische Industrie
Sales markets - target countries
Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Liechtenstein, Luxembourg, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States
Cooperation offers
not available